Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca_plaque_web_3

Positive Phase III trial results for AstraZeneca in flushing copper from tissues

August 26, 2021

AstraZeneca’s ALXN1840 demonstrated approximately three times greater copper mobilisation from tissues than standard-of-care treatments.Results from the FoCus Phase III trial …

News

NHS blood tests halted due to vial shortages

August 26, 2021

The NHS has suspended some blood testing due to a shortage in collection tube supplies following warnings from Becton Dickinson …

News

NHS England planning for possible jab roll out to 12-15 year-olds

August 26, 2021

NHS England is preparing for a possible extension of the COVID vaccination programme to all 12 to 15-year-olds.This will be …

News

Trial planned to investigate ketamine in treatment-resistant depression

August 25, 2021
Research and Development

HMNC Brain Health and Develco Pharma have partnered to develop an investigational oral prolonged-release formulation of ketamine, targeting treatment-resistant depression …

News
mark

Stelis Biopharma appoints Mark Womack as new CEO

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Stelis Biopharma Limited has announced the appointment of Mark W Womack as the new Chief Executive Officer.Womack is also the …

Appointment

PureTech appoints Julie Krop as Chief Medical Officer

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotherapeutics company PureTech has appointed Julie Krop as Chief Medical Officer.Krop will oversee all clinical development, Regulatory, CMC, and …

Appointment

Tracey Lodie appointed Chief Scientific Officer of Quell Therapeutics

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Quell Therapeutics has announced the appointment of Tracey Lodie as Chief Scientific Officer.Dr Lodie brings to Quell more than 20 …

Appointment
anita_cooper_002

RareCan appoints Dr Anita Cooper as Non-Executive Director

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cancer research company RareCan has appointed Dr Anita Cooper as Non-Executive Director.Cooper has over 30 years’ experience in global business …

Appointment

Laura Steele appointed President and General Manager for Lilly UK

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Eli Lilly and Company have announced that Laura Steele has been appointed President and General Manager (GM) for UK, Ireland …

Appointment

Medical cannabis: The next innovation in oncology?

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp …

Feature
drugcosts-edt-jumbo

Pharma disputes, fines, and the work of the CMA

August 25, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Several pharmaceutical firms have lately been fined for unfairly hiking prices over the years, meaning that patients and the NHS …

Feature

One-time gene therapy sees promising results in children with AADC deficiency

August 25, 2021
Research and Development

A pioneering approach to gene therapy delivery has been published in the European Molecular Biology Organization Journal on Wednesday, wherein …

News

Generic asthma inhaler to offer NHS significant savings

August 25, 2021
Research and Development

Luforbec 100/6 pMDI, the first branded generic alternative to Fostair 100/6 pMDI, to treat adult asthma and severe chronic obstructive …

News

Protection from COVID-19 vaccines starts to wane within six months

August 25, 2021
Research and Development

Researchers are starting to see that protection from the COVID-19 vaccines begins to wane within sixe months of receiving a …

News

Pfizer to buy Trillium for $2.26 billion

August 25, 2021
Research and Development

Pfizer will buy Trillium, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, for $2.26 billion.Trillium’s …

News

Sackler family face “substantial risk” of liability over opioid crisis

August 24, 2021
Manufacturing and Production

The judge overseeing Purdue Pharma’s bankruptcy said that some members of the Sackler family, owners of OxyContin, face a “substantial …

News

Schools set to reopen as UK COVID deaths average 100 a day – highest since March

August 24, 2021
Manufacturing and Production

According to official data COVID-19 deaths in the UK are averaging at 100 a day, and scientists have warned that …

News
pfizer_building_logo2_1_3

Pfizer becomes first COVID vaccine to get full FDA approval

August 24, 2021
Manufacturing and Production

The FDA has given Pfizer’s COVID-19 vaccine full regulatory approval, making it the first to be officially licensed in the …

News

EC approves UCB’s plaque psoriasis treatment

August 24, 2021
Manufacturing and Production

UCB announced on Tuesday that the European Commission (EC) has granted marketing authorisation for Bimzelx (bimekizumab) for the treatment of …

News

FDA approves Cara & Vifor’s drug for severe itching in kidney disease patients

August 24, 2021
Manufacturing and Production

Vifor Pharma and Cara Therapeutics have gained FDA approval for Korsuva (difelikefalin) for the treatment of moderate-to-severe pruritus associated with …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026